... it received tentative Food and Drug Administration approval for a generic version of GlaxoSmithKline PLC's (NYSE:GSK) seizure treatment Lamictal. ...
... children was an average of 12 points lower when expectant mothers took valproate compared with three other drugs: Lamictal, carbamazepine and phenytoin. ...
... delays in winning regulatory approvals for migraine drug Trexima and new versions of epilepsy treatment Lamictal and Requip for Parkinson's disease and RLS.
... approval from the US Food and Drug Administration to market Lamotrigine tablets, the generic version of GlaxoSmithKline's antiepileptic drug Lamictal. ...
Mylan Inc. said it has received tentative approval from the Food and Drug Administration to market the generic version of GlaxoSmithKline's Lamictal, ...
Lamotrigine Tablets are the generic version of GlaxoSmithKline's Lamictal(R) Tablets, which had US sales of approximately $1.97 million for the 12 months ...
... said Wednesday it received tentative Food and Drug Administration approval for a generic version of GlaxoSmithKline PLC's seizure treatment Lamictal. ...
Lamotrigine Tablets are the generic version of GlaxoSmithKline's Lamictal(R) Tablets, which had US sales of approximately $1.97 million for the 12 months ...
... version of GlaxoSmithKline's (GSK, GSK.L) Lamictal Tablets, which had US sales of approximately $1.97 million for the 12 months ending Sept. 30, 2007.
Lamotrigine tablets are a generic version of GlaxoSmithKline's Lamictal tablets, which had US sales of $1.97 million for the 12 months ended Sept. 30. ...